|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0034897,
umls-concept:C0040135,
umls-concept:C0086418,
umls-concept:C0205210,
umls-concept:C0443324,
umls-concept:C0547070,
umls-concept:C1441129,
umls-concept:C1521828,
umls-concept:C1548559,
umls-concept:C2348205,
umls-concept:C2825032
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-1
|
|
pubmed:abstractText |
Recent studies have confirmed that radioactive iodine therapy after recombinant human TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no published study has determined the effectiveness of rhTSH preparations on the important endpoint of disease recurrence.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
764-70
|
|
pubmed:dateRevised |
2009-6-16
|
|
pubmed:meshHeading |
pubmed-meshheading:18413378-Adolescent,
pubmed-meshheading:18413378-Adult,
pubmed-meshheading:18413378-Aged,
pubmed-meshheading:18413378-Aged, 80 and over,
pubmed-meshheading:18413378-Biological Markers,
pubmed-meshheading:18413378-Catheter Ablation,
pubmed-meshheading:18413378-Child,
pubmed-meshheading:18413378-Female,
pubmed-meshheading:18413378-Humans,
pubmed-meshheading:18413378-Iodine Radioisotopes,
pubmed-meshheading:18413378-Male,
pubmed-meshheading:18413378-Middle Aged,
pubmed-meshheading:18413378-Recombinant Proteins,
pubmed-meshheading:18413378-Recurrence,
pubmed-meshheading:18413378-Retrospective Studies,
pubmed-meshheading:18413378-Risk,
pubmed-meshheading:18413378-Thyroglobulin,
pubmed-meshheading:18413378-Thyroid Neoplasms,
pubmed-meshheading:18413378-Thyrotropin,
pubmed-meshheading:18413378-Time Factors,
pubmed-meshheading:18413378-Treatment Outcome,
pubmed-meshheading:18413378-Whole Body Imaging
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.
|
|
pubmed:affiliation |
Division of Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
